New hope for kids with arthritis: real-world study tests tofacitinib
NCT ID NCT07211932
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 24 times
Summary
This study looks at how well the drug tofacitinib works for children with juvenile idiopathic arthritis (JIA). Researchers will use real-world medical records from 58 children under 18 to see if the drug improves arthritis control after 12 months. The goal is to reduce disease activity and help kids feel better, but ongoing treatment is needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for JUVENILE IDIOPATHIC ARTHRITIS (JIA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Corporació Sanitària Parc Taulí de Sabadell
Sabadell, Barcelona, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hospital Sant Joan de Déu Barcelona
Barcelona, Barcelona, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hospital de Vilafranca
Vilafranca del Penedès, Barceona, 08720, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.